A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder

Anja Tränkner, Christian Sander, Peter SchönknechtDepartment of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, GermanyAbstract: The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to hav...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tränkner A, Sander C, Schönknecht P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/8010f925b61442a682ccbcea6297c6bd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8010f925b61442a682ccbcea6297c6bd
record_format dspace
spelling oai:doaj.org-article:8010f925b61442a682ccbcea6297c6bd2021-12-02T00:59:14ZA critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder1176-63281178-2021https://doaj.org/article/8010f925b61442a682ccbcea6297c6bd2013-01-01T00:00:00Zhttp://www.dovepress.com/a-critical-review-of-the-recent-literature-and-selected-therapy-guidel-a12005https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Anja Tränkner, Christian Sander, Peter SchönknechtDepartment of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, GermanyAbstract: The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to have antidepressant effects in the treatment of bipolar disorder. It is recommended by certain therapy guidelines as a first-line agent for acute and maintenance therapy in bipolar depression, but there have been only some promising results of placebo-controlled trials on its acute antidepressant effects, and the recommendation in therapy guidelines has been reconsidered. On the contrary, positive results for maintenance therapy could be confirmed, and LTG is still a well-tolerated option, especially in patients with predominant depressive episodes. Antimanic effects are not shown in the literature, and its use is not advised in any guidelines that were examined. In conclusion, the findings of the present review article on treatment guidelines for bipolar disorder question the role of LTG in acute depressive states, and critically discusses its use, particularly in acute depressive states.Keywords: lamotrigine, bipolar disorder, bipolar depressionTränkner ASander CSchönknecht PDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 101-111 (2013)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Tränkner A
Sander C
Schönknecht P
A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
description Anja Tränkner, Christian Sander, Peter SchönknechtDepartment of Psychiatry and Psychotherapy, University Hospital Leipzig, Leipzig, GermanyAbstract: The anticonvulsant drug lamotrigine (LTG), a sodium channel blocker and inhibitor of glutamate release, has been found to have antidepressant effects in the treatment of bipolar disorder. It is recommended by certain therapy guidelines as a first-line agent for acute and maintenance therapy in bipolar depression, but there have been only some promising results of placebo-controlled trials on its acute antidepressant effects, and the recommendation in therapy guidelines has been reconsidered. On the contrary, positive results for maintenance therapy could be confirmed, and LTG is still a well-tolerated option, especially in patients with predominant depressive episodes. Antimanic effects are not shown in the literature, and its use is not advised in any guidelines that were examined. In conclusion, the findings of the present review article on treatment guidelines for bipolar disorder question the role of LTG in acute depressive states, and critically discusses its use, particularly in acute depressive states.Keywords: lamotrigine, bipolar disorder, bipolar depression
format article
author Tränkner A
Sander C
Schönknecht P
author_facet Tränkner A
Sander C
Schönknecht P
author_sort Tränkner A
title A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
title_short A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
title_full A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
title_fullStr A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
title_full_unstemmed A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
title_sort critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/8010f925b61442a682ccbcea6297c6bd
work_keys_str_mv AT trampaumlnknera acriticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
AT sanderc acriticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
AT schampoumlnknechtp acriticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
AT trampaumlnknera criticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
AT sanderc criticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
AT schampoumlnknechtp criticalreviewoftherecentliteratureandselectedtherapyguidelinessince2006ontheuseoflamotrigineinbipolardisorder
_version_ 1718403395506667520